Maxim Group slashes price target on Brainstorm Cell Therapeutics, Inc. [BCLI] – find out why.
Brainstorm Cell Therapeutics, Inc. [NASDAQ: BCLI] stock went on a downward path that fall over -20.21% on Tuesday, amounting to a one-week price decrease of less than -18.98%. The company report on April 9, 2024 at 6:00 AM that BrainStorm Cell Therapeutics Announces Agreement with